Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigeo Yoshida

Showing results (331-340 of 332) with videos related to

Pageof 34
Sort By:
You have reached the last page of results.This site can display upto 332 results.
Retina (Philadelphia, Pa.)|October 18, 2024
ALTERATION OF TREATMENT CHOICES AND THE VISUAL PROGNOSIS FOR DIABETIC MACULAR EDEMA IN THE ERA OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR DRUGS: Analysis of the STREAT-DME 2 StudyMasahiko Shimura, Takao Hirano, Eiko Tsuiki, et al.
Ophthalmology|November 24, 2022
Genome-Wide Association Study of Age-Related Macular Degeneration Reveals 2 New Loci Implying Shared Genetic Components with Central Serous ChorioretinopathyMasato Akiyama, Masahiro Miyake, Yukihide Momozawa, et al.
Pageof 34

Showing results (331-340 of 332) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 332 results.
Retina (Philadelphia, Pa.)|October 18, 2024
ALTERATION OF TREATMENT CHOICES AND THE VISUAL PROGNOSIS FOR DIABETIC MACULAR EDEMA IN THE ERA OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR DRUGS: Analysis of the STREAT-DME 2 StudyMasahiko Shimura, Takao Hirano, Eiko Tsuiki, et al.
Ophthalmology|November 24, 2022
Genome-Wide Association Study of Age-Related Macular Degeneration Reveals 2 New Loci Implying Shared Genetic Components with Central Serous ChorioretinopathyMasato Akiyama, Masahiro Miyake, Yukihide Momozawa, et al.
Pageof 34